Data as of Jan 30
| -0.30 / -0.80%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 37.25, with a high estimate of 47.14 and a low estimate of 21.05. The median estimate represents a +0.44% increase from the last price of 37.09.
The current consensus among 32 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.